Home ›
Our Work ›
Kochon Prize
Selection Criteria
Selection Committee will primarily consider:
- A nominee's substantive contribution to the fight against TB.
- Extent to which the Kochon Prize will contribute to furthering the nominee's work in the fight against TB.
Selection Committee is composed of:
Mr Timur Abdullaev
Global Coalition of TB Activists
Uzbekistan
Dr Kenneth Castro
Clinical Assistant Professor, Emory University School of Public Health
United States of America
Dr Paula Fujiwara
Scientific Director, International Union Against Tuberculosis and Lung Disease
France
Mr. Woo Young Soo
Executive Director, Kochon Foundation
Republic of Korea
Dr Mel Spigelman
President and CEO, Global Alliance for TB Drug Development
Co-Chair, Working Group on New TB Drugs
United States of America